140 related articles for article (PubMed ID: 37835455)
1. Thyroid Cancer: Focus on Invasion and Metastasis Mechanisms, Therapeutic Target and Drug Treatment.
Vasko V
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835455
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis.
Vasko VV; Saji M
Curr Opin Oncol; 2007 Jan; 19(1):11-7. PubMed ID: 17133106
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
[TBL] [Abstract][Full Text] [Related]
4. Expression of ANGPTL2 and its impact on papillary thyroid cancer.
Yang L; Sun R; Wang Y; Fu Y; Zhang Y; Zheng Z; Ji Z; Zhao D
Cancer Cell Int; 2019; 19():204. PubMed ID: 31384179
[TBL] [Abstract][Full Text] [Related]
5. IL-17RB enhances thyroid cancer cell invasion and metastasis via ERK1/2 pathway-mediated MMP-9 expression.
Ren L; Xu Y; Liu C; Wang S; Qin G
Mol Immunol; 2017 Oct; 90():126-135. PubMed ID: 28715683
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA MEG3 suppresses migration and invasion of thyroid carcinoma by targeting of Rac1.
Wang C; Yan G; Zhang Y; Jia X; Bu P
Neoplasma; 2015; 62(4):541-9. PubMed ID: 25997963
[TBL] [Abstract][Full Text] [Related]
7. Silencing of PPM1D inhibits cell proliferation and invasion through the p38 MAPK and p53 signaling pathway in papillary thyroid carcinoma.
Lu ZW; Wen D; Wei WJ; Han LT; Xiang J; Wang YL; Wang Y; Liao T; Ji QH
Oncol Rep; 2020 Mar; 43(3):783-794. PubMed ID: 31922231
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer.
Hamidi AA; Taghehchian N; Basirat Z; Zangouei AS; Moghbeli M
Biomark Res; 2022 Jun; 10(1):40. PubMed ID: 35659780
[TBL] [Abstract][Full Text] [Related]
9. Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells.
Shang H; Zhao J; Yao J; Wang H; Wang S; Dong J; Liao L
Thorac Cancer; 2019 Dec; 10(12):2243-2252. PubMed ID: 31631580
[TBL] [Abstract][Full Text] [Related]
10. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance.
Mashouri L; Yousefi H; Aref AR; Ahadi AM; Molaei F; Alahari SK
Mol Cancer; 2019 Apr; 18(1):75. PubMed ID: 30940145
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs.
Aigner A
J Mol Med (Berl); 2011 May; 89(5):445-57. PubMed ID: 21234533
[TBL] [Abstract][Full Text] [Related]
12. SLC34A2 Up-regulation And SLC4A4 Down-regulation Correlates With Invasion, Metastasis, And The MAPK Signaling Pathway In Papillary Thyroid Carcinomas.
Huang F; Wang H; Xiao J; Shao C; Zhou Y; Cong W; Gong M; Sun J; Shan L; Hao Z; Wang L; Ding S; Yu Z; Liu J; Jia H
J Cancer; 2021; 12(18):5439-5453. PubMed ID: 34405007
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting
Yu C; Zhang L; Luo D; Yan F; Liu J; Shao S; Zhao L; Jin T; Zhao J; Gao L
Thyroid; 2018 Dec; 28(12):1627-1641. PubMed ID: 30244634
[No Abstract] [Full Text] [Related]
14. Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion.
Bauerle KT; Schweppe RE; Haugen BR
Mol Cancer; 2010 May; 9():117. PubMed ID: 20492683
[TBL] [Abstract][Full Text] [Related]
15. Keep your eyes peeled for long noncoding RNAs: Explaining their boundless role in cancer metastasis, drug resistance, and clinical application.
Barik GK; Sahay O; Behera A; Naik D; Kalita B
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188612. PubMed ID: 34391844
[TBL] [Abstract][Full Text] [Related]
16. Aurora kinase A induces papillary thyroid cancer lymph node metastasis by promoting cofilin-1 activity.
Maimaiti Y; Jie T; Jing Z; Changwen W; Pan Y; Chen C; Tao H
Biochem Biophys Res Commun; 2016 Apr; 473(1):212-218. PubMed ID: 27003257
[TBL] [Abstract][Full Text] [Related]
17. KAT5 promotes invasion and metastasis through C-MYC stabilization in ATC.
Wei X; Cai S; Boohaker RJ; Fried J; Li Y; Hu L; Pan Y; Cheng R; Zhang S; Tian Y; Gao M; Xu B
Endocr Relat Cancer; 2019 Jan; 26(1):141-151. PubMed ID: 30400007
[TBL] [Abstract][Full Text] [Related]
18. Expression of MMP-13 is associated with invasion and metastasis of papillary thyroid carcinoma.
Wang JR; Li XH; Gao XJ; An SC; Liu H; Liang J; Zhang K; Liu Z; Wang J; Chen Z; Sun W
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):427-35. PubMed ID: 23467939
[TBL] [Abstract][Full Text] [Related]
19. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
[TBL] [Abstract][Full Text] [Related]
20. h-prune affects anaplastic thyroid cancer invasion and metastasis.
Nambu J; Kobayashi T; Hashimoto M; Tashiro H; Sugino K; Shimamoto F; Kikuchi A; Ohdan H
Oncol Rep; 2016 Jun; 35(6):3445-52. PubMed ID: 27109060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
